Streetbeat News

Stock Prices

HZO

MarineMax (NYSE:HZO) has received a mix of bullish and bearish ratings from six analysts over the past three months. The average 12-month price target has increased by 10.48% to $42.17. Analysts have raised their price targets, reflecting positive sentiment and financial performance, including a 4.97% revenue growth rate and strong profitability metrics.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 2:00 pm

APO

Apollo Global Management (NYSE:APO) has outperformed the market over the past 10 years with an average annual return of 16.58%, significantly increasing the value of investments over time.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 2:00 pm

HLNE

Hamilton Lane shares rose following the announcement of its addition to the S&P MidCap 400 index.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:56 pm

IBRX

ImmunityBio shares rose following the presentation of positive long-term survival data for non-small cell lung cancer patients and the announcement of Phase 3 trials with ANKTIVA and checkpoint immunotherapy.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:55 pm

EGIO

INBS

MEOH

PEGY

RLAY

SINT

WHLR

US stocks rose with the Dow Jones gaining over 200 points. Methanex Corporation announced a $2.05 billion acquisition of OCI Global's methanol business. Sintx Technologies, Intelligent Bio Solutions, and Relay Therapeutics saw significant stock price increases, while Edgio, Pineapple Energy, and Wheeler Real Estate Investment Trust experienced declines.

Portfolio Pulse from Avi Kapoor

September 09, 2024 | 1:54 pm

TLRY

Tilray Medical, a division of Tilray Brands, Inc., announced a study showing that cannabinoid treatment significantly reduces fibromyalgia pain and improves quality of life. The study highlights the potential of cannabinoids as a cost-effective treatment option.

Portfolio Pulse from Jelena Martinovic

September 09, 2024 | 1:50 pm

ASML

Options trading for ASML Holding shows a bearish sentiment among large investors, with 58% of trades being bearish. The price range targeted by these trades is between $510 and $1140. ASML's stock is currently up 1.07% at $760.84, with RSI indicators suggesting it may be oversold.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 1:46 pm

NFLX

Financial giants are showing a bullish trend on Netflix (NASDAQ:NFLX) with 66% of options trades being bullish. Analysts have set high price targets, and the stock is currently up 1.18% at $673.6. The next earnings report is expected in 37 days.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 1:46 pm

AMD

Deep-pocketed investors are showing a bullish sentiment towards Advanced Micro Devices (AMD) through significant options activity. Benzinga's options scanner highlighted 13 extraordinary options activities, with a mix of bullish and bearish sentiments. The price window eyed by these investors ranges from $95 to $160. AMD's stock is currently trading at $135.68, up by 0.99%.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 1:46 pm

GSK

GSK presented late-breaking data at the ERS showing that their drug Depemokimab significantly reduces severe asthma exacerbations by 54% in Phase III trials. The SWIFT-1 and SWIFT-2 studies demonstrated meaningful reductions over 52 weeks compared to placebo.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 1:38 pm